Disorders of thyroid, IBD co-morbidities

THYROID_DISORDER_IBD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints THYROTOXICOSIS THYROIDITIS DIS_THYROID_OTH	14931
6. Filter based on genotype QC (FinnGen only)	14427

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	THYROID_DISORDER_IBD
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	THYROTOXICOSIS\|THYROIDITIS\|DIS_THYROID_OTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of thyroid, IBD co-morbidities based on the number of shared cases.

Similar with more cases:

Endocrine, nutritional and metabolic diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14427	11518	2909
Unadjusted period prevalence (%)	3.53	4.09	1.33
Median age at first event (years)	51.76	50.03	58.58

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11164: Matched controls
78442

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L15

ICPC

Knee symptom/complaint

2.9

322.8

1886

5078

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

321.4

3710

13952

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.4

320.3

752

1033

L13

ICPC

Hip symptom/complaint

3.5

318.2

1329

2906

A02BC03

ATC

lansoprazole; oral

2.6

314.0

2401

7452

A10AB05

ATC

insulin aspart; parenteral

55.4

307.7

647

B01AB05

ATC

enoxaparin; parenteral

2.7

307.7

2697

8398

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

64.8

307.7

443

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.5

307.7

1710

3824

R06.0

ICD-10 Finland

Dyspnoea

3.4

307.7

2498

6069

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

22.3

307.7

393

128

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.1

307.7

4229

12806

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

72.8

307.7

371

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

7.2

307.7

653

673

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

42.7

307.7

438

Z01.8

ICD-10 Finland

Other specified special examinations

3.2

307.7

2135

5433

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.6

307.7

907

899

R42

ICD-10 Finland

Dizziness and giddiness

3.1

307.7

1906

4948

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

97.4

307.7

297

H03AA01

ATC

levothyroxine sodium; systemic

14.4

307.7

6591

7127

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

93.6

307.7

605

N02BF01

ATC

gabapentin; oral

10.3

307.7

610

438

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

138.5

307.7

288

ZXA00

NOMESCO Finland

Right side

2.9

307.7

1972

5355

A10BA02

ATC

metformin; oral

24.8

307.7

1954

666

N03AX16

ATC

[U] pregabalin

6.7

307.7

2022

2522

N03AX12

ATC

[U] gabapentin; oral

12.3

307.7

1390

894

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.1

307.7

1921

4873

207

Kela drug reimbursment

Chronic arrhythmias

4.0

307.7

1253

2414

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.9

307.7

1188

2328

ACC51

NOMESCO Finland

Release of median nerve

380.1

307.7

565

A10BK03

ATC

empagliflozin; oral

92.2

307.7

620

M01AX05

ATC

glucosamine; oral

4.4

307.7

1102

1924

M25.5

ICD-10 Finland

Pain in joint

4.2

307.7

3120

6657

A02BC02

ATC

pantoprazole; systemic

3.3

307.7

7003

26361

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

307.7

3770

13440

ZXE10

NOMESCO Finland

More than one and less than three hours

2.6

307.7

3430

11340

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.7

307.7

1038

1664

M54.5

ICD-10 Finland

Low back pain

3.5

307.7

3444

8946

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

9.7

307.7

774

597

EP1AE

NOMESCO Finland

Neck ultrasound examination

7.4

307.7

1111

1161

104

Kela drug reimbursment

Thyroid insufficiency

16.6

307.7

2392

1264

N06AA09

ATC

amitriptyline; systemic

6.5

307.7

687

781

E03.89

ICD-10 Finland

Other specified hypothyroidism

10.5

307.7

879

633

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

7.8

307.7

600

564

L03

ICPC

Low back symptom/complaint

2.7

307.7

2531

7569

215

Kela drug reimbursment

Diabetes, non-insulin-treated

421.3

307.7

1893

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

185.5

307.7

333

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

37.0

307.7

401

M13.9

ICD-10 Finland

Arthritis, unspecified

11.0

307.7

533

355

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

12.8

307.7

889

525

R51.80

ICD-10 Finland

Headache

4.0

307.7

1565

3084

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.5

307.7

1152

1975

T89

ICPC

Diabetes insulin dependent

94.5

307.7

402

N02AJ06

ATC

codeine and paracetamol; systemic

3.1

307.7

3964

11785

N02AX02

ATC

tramadol; systemic, rectal

4.0

307.7

3896

9284

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

2025.4

307.7

1316

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

9.0

307.7

542

440

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

6.4

307.7

643

737

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

16.6

307.7

772

349

M01AH01

ATC

celecoxib; oral

3.8

307.7

1316

2686

A10AC01

ATC

insulin (human); parenteral

18.1

307.7

656

270

NF1AA

NOMESCO Finland

Hip X-ray examination

10.7

307.7

498

342

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

16.8

307.7

684

304

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

26.1

307.7

423

118

E06.3

ICD-10 Finland

Autoimmune thyroiditis

68.5

307.7

635

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

31.8

307.7

742

175

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.1

307.7

1870

3670

A10BH01

ATC

sitagliptin; oral

849.7

307.7

574

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1091.8

307.7

582

L17

ICPC

Foot/toe symptom/complaint

2.7

307.7

2478

7562

M17.1

ICD-10 Finland

Other primary gonarthrosis

14.1

307.7

1408

796

C07AB07

ATC

bisoprolol; oral

4.8

307.7

5437

12985

Z3226

NOMESCO Finland

Physiotherapist

3.4

307.7

1545

3545

E03

ICD-10 Finland

Other hypothyroidism

5.2

307.7

1087

1597

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

2422

6678

A02BC05

ATC

esomeprazole; systemic

2.5

307.7

3868

13508

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.8

307.7

703

893

A07EC01

ATC

sulfasalazine; oral, rectal

11.5

307.7

537

342

T85

ICPC

Hyperthyroidism/thyrotoxicosis

92.4

307.7

430

J01AA02

ATC

doxycycline; systemic

2.3

307.7

7917

40002

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

175.8

307.7

1206

M01AB05

ATC

diclofenac; systemic, rectal

2.2

307.7

6416

29515

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

43.3

307.7

1613

305

M19.0

ICD-10 Finland

Primary arthrosis of other joints

13.5

307.7

641

353

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

356

M01AH05

ATC

etoricoxib; oral

2.6

307.7

5979

23983

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

20.2

307.7

1146

442

M79.0

ICD-10 Finland

Rheumatism, unspecified

58.3

307.7

283

R5140

NOMESCO Finland

Monitoring the use of the aid

12.5

307.7

752

449

A10AB01

ATC

insulin (human); parenteral

126.9

307.7

333

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

28.4

307.7

791

210

S18

ICPC

Laceration/cut

2.3

307.7

3833

14502

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

301.3

307.7

531

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

291.7

307.7

915

H03BB01

ATC

carbimazole; oral

1450.8

307.7

6763

N02BE01

ATC

paracetamol; systemic, rectal

3.7

307.7

9417

46607

M01AC06

ATC

meloxicam; systemic, rectal

2.5

307.7

3001

9939

G44.2

ICD-10 Finland

Tension-type headache

4.6

307.7

1374

2302

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

14909.3

307.7

4876

M79.6

ICD-10 Finland

Pain in limb

3.6

307.7

3992

10480

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.8

307.7

1091

1745

H02AB06

ATC

prednisolone; systemic

3.6

307.7

5255

15583

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

307.7

4727

17788

T90

ICPC

Diabetes non-insulin dependent

21.0

307.7

1579

612

S06.0

ICD-10 Finland

Concussion

10.5

307.7

812

582

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.1

307.7

3641

8340

A10AB04

ATC

insulin lispro; parenteral

93.5

307.7

323

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

312.5

307.7

862

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

21.3

307.7

358

122

L04AX03

ATC

methotrexate; systemic

10.5

307.7

703

500

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

30.4

307.7

638

156

C07AB02

ATC

metoprolol; systemic

3.4

307.7

1752

4023

G56.0

ICD-10 Finland

Carpal tunnel syndrome

12.6

307.7

1170

721

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

307.7

973

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

42.8

307.7

1164

213

M54.4

ICD-10 Finland

Lumbago with sciatica

5.4

307.7

1578

2308

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

18.2

307.7

608

248

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.3

307.7

2324

5714

M79.7

ICD-10 Finland

Fibromyalgia

18.6

307.7

329

128

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

307.7

2674

6630

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

81.9

307.7

512

C10AA05

ATC

atorvastatin; oral

2.6

307.7

3012

9632

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

9.8

307.7

530

398

M03BC01

ATC

orphenadrine (citrate); systemic

2.8

307.7

2140

6029

N06AX11

ATC

mirtazapine; oral

2.4

307.7

3143

10854

E11

ICD-10 Finland

Type 2 diabetes mellitus

20.0

307.7

944

360

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

375.1

307.7

462

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

103.9

307.7

246

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

8.1

307.7

637

583

AA1AD

NOMESCO Finland

CT of head and brain

6.1

307.7

2104

2876

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

307.7

2025

5501

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

307.7

4382

15773

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.5

307.7

4254

11766

A10BK01

ATC

dapagliflozin; oral

50.8

307.7

471

C03CA01

ATC

furosemide; systemic

3.8

307.7

2204

4717

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2494.1

307.7

4205

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.4

307.7

1639

3730

M03BX02

ATC

tizanidine; oral

2.4

307.7

6344

27547

R03AC02

ATC

salbutamol; inhalant

2.3

307.7

5672

24515

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

158.6

307.7

350

T86

ICPC

Hypothyroidism/myxoedema

6.8

307.7

876

972

M48.0

ICD-10 Finland

Spinal stenosis

48.4

307.7

728

113

BAA60

NOMESCO Finland

Total thyroidectomy

34.4

307.7

1610

382

SPAT1262

SPAT

Handing over of treatment supplies

6.7

307.7

1370

1605

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

122.2

307.7

255

M16.1

ICD-10 Finland

Other primary coxarthrosis

23.5

307.7

647

205

M70.6

ICD-10 Finland

Trochanteric bursitis

4.9

307.7

996

1536

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.8

307.7

1984

4207

L28

ICPC

Limited function/disability (L)

5.1

307.7

1275

1919

103

Kela drug reimbursment

Diabetes, insulin-treated

286.4

307.7

1980

E05.89

ICD-10 Finland

Other thyrotoxicosis

+∞

307.7

445

P01BA02

ATC

hydroxychloroquine; oral

21.3

307.7

615

214

E06.9

ICD-10 Finland

Thyroiditis, unspecified

176.5

307.7

388

A10BB12

ATC

glimepiride; oral

116.6

307.7

291

A10AE04

ATC

insulin glargine; parenteral

77.0

307.7

766

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

307.7

635

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

46.1

307.7

793

130

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

388

C01BD01

ATC

amiodarone; systemic

11.4

307.7

540

347

N06AX21

ATC

duloxetine; oral

5.6

307.7

1068

1450

G47.3

ICD-10 Finland

Sleep apnoea

15.7

307.7

1842

975

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

7.1

307.7

2460

2983

R53

ICD-10 Finland

Malaise and fatigue

2.8

307.7

2500

7328

A10AE05

ATC

insulin detemir; parenteral

222.1

307.7

455

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

12.4

307.7

898

550

C07AA05

ATC

propranolol; systemic

5.7

307.7

3922

6823

B01AA03

ATC

warfarin; systemic

3.4

307.0

1384

3179

I50.9

ICD-10 Finland

Heart failure, unspecified

4.4

306.9

928

1595

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

8.9

306.9

463

379

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

17.0

305.9

321

136

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

14.8

304.1

340

166

C10AA01

ATC

simvastatin; oral

2.5

303.7

2690

8948

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

303.5

3133

11173

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

70.1

303.4

225

N05CF01

ATC

zopiclone; oral

2.4

303.3

2806

9525

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

303.1

2299

7094

J01DB01

ATC

cefalexin; oral

2.4

301.8

8668

46556

A10BJ06

ATC

semaglutide; parenteral

+∞

299.4

329

C08CA01

ATC

amlodipine; oral

2.4

299.1

2688

8994

M01AE02

ATC

naproxen; oral, rectal

2.1

298.4

5540

25017

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.8

294.7

1060

2082

A02BC01

ATC

omeprazole; systemic

2.5

292.7

2424

7794

R4110

NOMESCO Finland

Physiotherapy

2.6

292.6

2317

7290

XCK10

NOMESCO Finland

Photography of fundus of eye

5.1

292.4

731

1064

M02AA07

ATC

piroxicam; topical

2.4

291.7

2883

10059

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

12.1

290.9

361

216

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.6

287.9

652

863

M79.1

ICD-10 Finland

Myalgia

3.2

285.7

1349

3185

A28

ICPC

Limited function/disability NOS

3.9

282.6

1008

1966

J45.9

ICD-10 Finland

Asthma, unspecified

2.9

281.8

1673

4521

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

574.2

281.0

318

B01AF01

ATC

rivaroxaban; oral

4.5

280.6

818

1362

N80.1

ICD-10 Finland

Endometriosis of ovary

58.7

280.5

213

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

30.5

280.4

242

UJF32

NOMESCO Finland

Coloscopy

2.6

280.4

2137

6585

WX320

NOMESCO Finland

Spinalanesthesy

2.7

280.1

1886

5455

Z3231

NOMESCO Finland

Registered nurse

2.4

279.6

2484

8236

M20.1

ICD-10 Finland

Hallux valgus (acquired)

7.4

279.2

484

476

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.0

275.0

1548

4056

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

272.5

2433

8075

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

272.0

1299

3084

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

270.8

2584

8836

H02AB07

ATC

prednisone; oral

3.2

268.7

1312

3157

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.5

268.3

1109

2397

L88

ICPC

Rheumatoid/seropositive arthritis

33.6

267.1

225

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

267.0

2127

6682

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

5.2

265.2

648

922

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

263.5

2581

8916

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.9

263.2

1549

4156

A10AE06

ATC

insulin degludec; parenteral

1072.4

262.0

293

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

18.2

259.0

264

104

NE1AA

NOMESCO Finland

Pelvis X-ray examination

8.1

257.8

416

373

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

257.6

2187

7071

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

40.2

256.9

208

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

256.8

1315

3253

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.3

256.7

614

856

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

78.6

255.5

187

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

127.8

255.1

179

SPAT1153

SPAT

Removal of sutures

2.4

254.4

2442

8345

G43.9

ICD-10 Finland

Migraine, unspecified

5.6

253.5

570

748

M01AX17

ATC

nimesulide; oral

2.7

253.0

1703

4906

C10AA07

ATC

rosuvastatin; oral

2.3

251.7

2437

8355

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

251.0

276

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

10.1

250.9

347

249

M54.3

ICD-10 Finland

Sciatica

7.1

250.5

447

455

B01AC04

ATC

clopidogrel; oral

3.8

249.7

891

1734

205

Kela drug reimbursment

Chronic hypertension

2.7

248.6

1643

4685

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

4.5

248.0

706

1150

L08

ICPC

Shoulder symptom/complaint

2.7

247.8

1729

5070

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

247.5

1665

4791

B01AF02

ATC

apixaban; oral

3.8

247.3

904

1790

L90

ICPC

Osteoarthrosis of knee

9.3

245.7

359

280

ZXA05

NOMESCO Finland

Left side

2.6

244.6

1766

5266

TFP20

NOMESCO Finland

Cardiodefibrillation

4.5

244.4

709

1173

J01FF01

ATC

clindamycin; systemic

2.3

242.3

2410

8344

N02BF02

ATC

pregabalin; oral

7.2

240.6

428

434

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

61.5

240.0

181

SPAT1263

SPAT

Sampling

2.0

237.9

3924

16574

N05BA04

ATC

oxazepam; oral

2.3

236.8

2377

8254

R4120

NOMESCO Finland

Occupational therapy

6.6

236.6

454

503

A10AA02, ,

ATC

223.1

235.9

277

M54.1

ICD-10 Finland

Radiculopathy

12.2

233.6

288

170

L01BA01

ATC

methotrexate; systemic

25.9

232.7

210

ZXA10

NOMESCO Finland

Bilateral

2.6

232.4

1613

4706

E66.01

ICD-10 Finland

Obesity due to excess calories

4.0

231.7

785

1468

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

231.0

1591

4623

J01DA01

ATC

[U] cefalexin

1.9

229.8

6168

30679

M43.1

ICD-10 Finland

Spondylolisthesis

22.0

229.3

218

H04AA01

ATC

glucagon; nasal, parenteral

239.6

229.2

268

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

89.9

227.1

164

A10BJ02

ATC

liraglutide; parenteral

50.2

226.3

176

C09AA05

ATC

ramipril; oral

2.6

225.5

1691

5124

R00.2

ICD-10 Finland

Palpitations

3.5

225.4

935

2018

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

6.0

225.4

472

575

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

224.9

7377

39116

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.8

224.5

812

1593

C03DA01

ATC

spironolactone; oral

3.4

224.4

945

2060

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

37.5

224.0

184

M01AH02

ATC

rofecoxib; oral

3.7

222.9

817

1618

R60.0

ICD-10 Finland

Localized oedema

3.5

222.8

899

1904

SPAT1216

SPAT

Assessment of functional ability

3.3

222.3

993

2249

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

220.4

2552

9372

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.7

220.2

1456

4136

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

593.3

219.1

248

A10AA01, ,

ATC

260.5

219.0

255

M47.82

ICD-10 Finland

Other spondylosis, cervical region

16.8

218.4

230

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.6

217.7

1628

4920

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

+∞

217.2

239

SPAT1229

SPAT

Assessment of need for aid

6.0

217.0

449

540

N03AF02

ATC

oxcarbazepine; oral

26.7

216.8

194

M47.9

ICD-10 Finland

Spondylosis, unspecified

37.4

216.5

178

N80.0

ICD-10 Finland

Endometriosis of uterus

31.5

216.2

185

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

204.5

216.1

255

A01

ICPC

Pain general/multiple sites

4.1

216.0

706

1283

A10BH05

ATC

linagliptin; oral

868.5

215.5

242

C10AX09

ATC

ezetimibe; oral

3.2

214.7

1019

2396

M54.2

ICD-10 Finland

Cervicalgia

4.4

214.6

628

1045

A11CC03

ATC

alfacalcidol; systemic

10.8

214.5

283

188

P01AB01

ATC

metronidazole; oral, rectal

1.9

213.8

3933

17114

ZXE00

NOMESCO Finland

One hour or less

2.0

212.7

3814

16445

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

212.4

3833

16561

XF404

NOMESCO Finland

Ambulatory ECG

3.8

212.2

760

1479

J01FA06

ATC

roxithromycin; oral

2.0

212.1

3696

15777

J02AC01

ATC

fluconazole; systemic

1.9

211.3

4296

19318

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

211.2

1190

3096

R02

ICPC

Shortness of breath/dyspnoea

3.1

210.2

1051

2550

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.3

209.8

638

1095

N05AH04

ATC

quetiapine; oral

2.5

209.7

1564

4715

WX722

NOMESCO Finland

PEEP

11.6

209.3

265

164

OAB50, ,

SPAT

7.9

209.0

344

316

N04BC05

ATC

pramipexole; oral

5.7

208.9

460

590

N06AX16

ATC

venlafaxine; oral

2.8

207.5

1283

3512

N06AB04

ATC

citalopram; systemic

2.4

206.5

1813

5899

E06.0

ICD-10 Finland

Acute thyroiditis

104.7

206.3

147

H04.10

ICD-10 Finland

Dry eye syndrome

2.9

205.9

1169

3053

WX780

NOMESCO Finland

Remote monitoring CPAP

828.1

205.5

231

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

203.5

224

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

24.6

203.0

186

J01MA02

ATC

ciprofloxacin; systemic

2.0

202.3

3323

13849

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

6.7

202.2

378

406

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.0

201.7

1042

2576

WX002

NOMESCO Finland

Sedation and analgesia

2.6

201.7

1444

4261

H53.2

ICD-10 Finland

Diplopia

7.9

201.6

330

301

WX723

NOMESCO Finland

CPAP therapy

239.5

201.0

235

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

200.8

3792

16569

SPAT1097

SPAT

Recording of ECG

2.9

199.5

1099

2819

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

62.8

199.4

150

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.9

197.9

515

774

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.7

197.1

1238

3413

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

196.6

1769

5809

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

40.2

195.1

158

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

22.3

194.5

184

A04

ICPC

Weakness/tiredness general

2.6

194.4

1357

3950

A02BA02

ATC

ranitidine; systemic

2.5

193.4

1444

4345

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.4

193.4

571

956

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

193.3

1474

4480

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

193.2

5512

27365

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

32.5

193.2

164

M22.4

ICD-10 Finland

Chondromalacia patellae

13.3

192.1

226

122

R01AD09

ATC

mometasone; nasal

1.8

192.0

4590

21563

M54.6

ICD-10 Finland

Pain in thoracic spine

4.0

190.4

638

1180

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.6

190.3

731

1493

E66.8

ICD-10 Finland

Other obesity

5.0

189.9

476

691

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.9

189.8

1031

2621

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.8

189.6

669

1286

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

66.9

188.9

141

XA800

NOMESCO Finland

Neuropsychological investigation

9.2

188.3

276

216

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

188.0

207

R5110, ,

SPAT

5.7

187.0

410

523

R52.9

ICD-10 Finland

Pain, unspecified

3.3

185.5

819

1835

N02AA05

ATC

oxycodone; systemic

2.8

185.4

1114

2994

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.8

185.3

492

752

WX402

NOMESCO Finland

General anaesthesia

2.1

185.3

2147

7823

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.5

183.7

526

858

R20.2

ICD-10 Finland

Paraesthesia of skin

3.9

183.4

620

1154

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.4

182.3

1517

4797

E66.00

ICD-10 Finland

Metabolic syndrome

6.3

181.5

362

418

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

27.3

181.3

161

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

180.7

2896

11885

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.5

180.3

408

537

R52.2

ICD-10 Finland

Other chronic pain

8.5

180.2

279

236

SPAT1301

SPAT

No procedures

2.0

179.7

2604

10311

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.1

179.1

318

321

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.8

178.4

3916

17806

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

63.5

178.4

134

L86

ICPC

Back syndrome with radiating pain

5.2

178.2

424

586

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

45.3

176.8

140

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

49.1

176.8

138

C09CA06

ATC

candesartan; oral

2.2

176.5

1905

6734

A10BB01

ATC

glibenclamide; oral

90.2

175.8

127

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

175.7

1173

3329

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

175.1

2681

10811

R50.9

ICD-10 Finland

Fever, unspecified

2.5

174.7

1342

4082

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.7

174.6

655

1314

C07AA07

ATC

sotalol; systemic

5.9

174.4

368

451

Z71.8

ICD-10 Finland

Other specified counselling

1.9

174.3

3039

12809

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.9

174.2

444

654

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

174.2

1116

3100

J01FA10

ATC

azithromycin; systemic

1.8

173.9

5941

30747

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

15.8

173.9

188

M04AA01

ATC

allopurinol; systemic

3.5

172.3

688

1441

H02AB04

ATC

methylprednisolone; systemic

2.6

172.1

1170

3350

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

171.8

1215

3548

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

171.6

189

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

11.6

171.5

217

134

N05BA01

ATC

diazepam; systemic, rectal

2.8

171.5

983

2571

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

31.5

170.7

146

M10.9

ICD-10 Finland

Gout, unspecified

6.3

170.6

340

392

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

170.2

5082

25240

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

170.1

855

2073

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

169.6

1745

6039

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

20.9

169.6

164

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

10.0

169.4

235

169

M01AB55

ATC

diclofenac, combinations; oral

5.1

169.2

419

601

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

19.1

169.2

169

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

7.5

169.1

287

274

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

18.5

168.9

171

C09AA02

ATC

enalapril; systemic

2.5

168.9

1260

3776

A10BD07

ATC

metformin and sitagliptin; systemic

456.7

168.4

192

C09CA01

ATC

losartan; oral

2.2

167.6

1761

6146

SPAT1310

SPAT

Counselling related to known health issue

1.9

167.5

2707

11097

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

232.1

167.3

196

K80

ICPC

Cardiac arrhythmia NOS

3.2

166.3

757

1727

TAB00

NOMESCO Finland

Lumbar puncture

7.0

165.7

300

310

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.3

165.2

386

524

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

78.1

165.1

121

R4110, ,

SPAT

3.6

164.8

628

1273

R05

ICPC

Cough

2.1

164.4

2136

8093

C08CA13

ATC

lercanidipine; oral

2.9

164.3

887

2241

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

11.1

163.9

212

136

E10

ICD-10 Finland

Type 1 diabetes mellitus

227.2

163.7

192

L01

ICPC

Neck symptom/complaint

2.4

163.4

1356

4269

M23.8

ICD-10 Finland

Other internal derangements of knee

8.0

163.1

263

235

XF402

NOMESCO Finland

ECG with work load test

3.2

162.8

746

1708

R06.5

ICD-10 Finland

Mouth breathing

3.6

162.5

627

1282

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

162.3

2743

11399

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

162.0

4594

22380

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

16.2

162.0

173

N80.9

ICD-10 Finland

Endometriosis, unspecified

21.9

162.0

154

M65.3

ICD-10 Finland

Trigger finger

6.7

162.0

302

323

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

7.4

161.0

277

269

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

194.5

160.6

190

R03DC03

ATC

montelukast; oral

2.3

160.0

1512

5040

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.2

159.9

499

872

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

+∞

159.7

176

R11

ICD-10 Finland

Nausea and vomiting

3.1

158.9

758

1779

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

44.8

158.8

126

M09AX01

ATC

hyaluronic acid; parenteral

9.8

158.6

222

162

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

222.9

158.4

186

J01FA09

ATC

clarithromycin; systemic

1.9

158.4

2918

12459

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.0

156.6

792

1925

K78

ICPC

Atrial fibrillation/flutter

4.0

156.1

518

949

L12

ICPC

Hand/finger symptom/complaint

2.4

156.1

1311

4145

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

80.9

156.1

114

J01CA04

ATC

amoxicillin; systemic

1.9

156.0

8569

50146

L89

ICPC

Osteoarthrosis of hip

15.2

155.7

171

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

155.6

1126

3319

G20

ICD-10 Finland

Parkinson disease

80.2

154.6

113

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.1

154.1

745

1762

R06AE07

ATC

cetirizine; oral

1.7

154.1

4368

21191

R01BA52

ATC

pseudoephedrine, combinations; oral

1.9

153.7

2729

11494

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

+∞

153.3

169

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

153.0

7419

41693

R13

ICD-10 Finland

Dysphagia

3.8

152.7

537

1027

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.0

152.1

806

2012

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.9

151.6

852

2199

G54.0

ICD-10 Finland

Brachial plexus disorders

10.8

151.5

199

131

M20.2

ICD-10 Finland

Hallux rigidus

19.4

151.1

150

C01AA05

ATC

digoxin; systemic

3.7

150.2

558

1110

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.9

149.8

505

936

C03AA03

ATC

hydrochlorothiazide; oral

3.7

149.8

549

1082

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.7

148.9

248

231

SPAT1254

SPAT

Administration of medicine

2.6

148.7

1046

3037

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.9

148.7

508

951

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1219.3

148.5

166

N03AF01

ATC

carbamazepine; oral, rectal

6.3

148.1

293

335

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

32.0

147.9

126

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.5

147.1

591

1241

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

146.9

630

1381

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

146.9

1239

3919

N03AX11

ATC

topiramate; oral

10.4

146.9

198

136

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

146.8

5302

27371

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

50.6

146.7

114

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

146.5

3344

15187

XA402

NOMESCO Finland

ENMG

17.0

146.3

153

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

146.1

161

P06

ICPC

Sleep disturbance

2.6

145.8

999

2862

R01AD08

ATC

fluticasone; nasal

1.8

145.7

2792

12018

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

10.2

145.5

199

140

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.0

144.9

363

526

G40.9

ICD-10 Finland

Epilepsy, unspecified

239.7

144.5

169

C01DA14

ATC

isosorbide mononitrate; oral

2.9

144.4

803

2059

G56.2

ICD-10 Finland

Lesion of ulnar nerve

11.0

144.4

188

122

M05BA04

ATC

alendronic acid; oral

3.9

144.1

494

927

SPAT1260

SPAT

Consultation of another employee

2.2

143.4

1404

4737

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.8

142.0

495

940

H062, E050,

ICD-10 Finland

+∞

141.5

156

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

18.5

141.4

143

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1153.0

141.2

158

G51.0

ICD-10 Finland

Bell palsy

22.5

141.2

133

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.3

141.1

1256

4066

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

7.3

140.7

243

237

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

+∞

140.6

155

N03AG01

ATC

valproic acid; systemic, rectal

4.3

140.3

418

703

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

26.9

140.2

125

R07.3

ICD-10 Finland

Other chest pain

2.9

140.2

771

1964

J01MA12

ATC

levofloxacin; systemic

2.2

139.1

1380

4677

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

26.1

139.0

125

N05CF02

ATC

zolpidem; oral

2.2

138.8

1515

5338

N03AE01

ATC

clonazepam; systemic

5.0

138.6

349

508

M50.3

ICD-10 Finland

Other cervical disc degeneration

19.1

137.2

137

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.6

137.1

380

602

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

136.8

569

1222

G04BD12

ATC

mirabegron; oral

3.0

136.0

709

1751

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.2

135.2

1369

4677

P20

ICPC

Memory disturbance

3.2

135.0

618

1411

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

39.0

135.0

110

NH3EA

NOMESCO Finland

Feet X-ray examination with load

60.3

134.8

102

Z50.1

ICD-10 Finland

Other physical therapy

5.2

134.7

323

449

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

134.5

1020

3066

R05FB02

ATC

cough suppressants and expectorants; systemic

1.8

134.3

3042

13717

NA1AD

NOMESCO Finland

Cervical spine CT examination

5.9

134.1

280

339

N06AB10

ATC

escitalopram; oral

2.0

133.7

1968

7739

L04AB01

ATC

etanercept; parenteral

64.4

133.3

100

E07.89

ICD-10 Finland

Other specified disorders of thyroid

55.6

133.2

102

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.5

133.0

1004

3011

I50.0

ICD-10 Finland

Congestive heart failure

4.1

132.6

417

732

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.5

131.4

523

1090

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

21.3

131.3

126

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

14.1

131.1

149

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

22.0

130.7

124

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2207

6470

2.74

323.31

1.7

1.4

25454007.18

26240296.35

pmol/l

0.02

1874

5545

(3030467) Casts [#/volume] in Urine by Automated count

2945

10003

2.45

320.24

3.3

2.3

0.33

0.49

e6/l

3.06

2256

6893

(3021601) Nitrite [Presence] in Urine by Test strip

5143

22176

2.17

318.67

5.2

3.4

0.00

estimate

2.33

1047

3995

(3009261) Glucose [Presence] in Urine by Test strip

5177

22429

2.16

316.19

3.9

2.4

0.00

estimate

0.75

1003

3989

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10157

53729

4.64

307.65

15.9

7.2

20.02

25.23

mg/l

44.52

8337

37262

(3019198) Lymphocytes [#/volume] in Blood

6051

20778

3.28

307.65

6.0

4.0

1.91

1.95

e9/l

0.75

5442

18256

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5556

23649

2.30

307.65

3.4

2.4

99.68

88.84

ug/l

3.43

5192

22416

(3013826) Glucose [Moles/volume] in Serum or Plasma

6263

21760

3.33

307.65

5.1

3.4

6.62

6.06

mmol/l

74.84

5869

19274

(3013512) EKG study

2948

9416

2.63

307.65

4.0

2.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4294

13029

3.14

307.65

2.0

1.5

96.62

96.82

pmol/l

0.09

2341

6840

(3026493) Urate [Moles/volume] in Serum or Plasma

2711

8104

2.78

307.65

2.5

2.0

2573.35

5632.09

umol/l

3.73

2359

7367

(3002582) Erythrocytes [#/volume] in Urine

3194

11165

2.41

307.65

3.4

2.3

79.39

121.87

e6/l

0.94

2480

7858

(3018095) Leukocytes [#/volume] in Urine

3754

14007

2.33

307.65

3.9

2.6

73.90

98.82

e6/l

1.37

2686

8664

(3023368) Bacteria identified in Blood by Culture

2658

8146

2.70

307.65

4.5

3.5

—

(3021589) Normoblasts [#/volume] in Blood

5096

20129

2.43

307.65

10.5

6.2

0.00

e9/l

0.31

4218

16162

(3006504) Eosinophils/100 leukocytes in Blood

5571

19025

3.11

307.65

6.1

4.1

2.83

2.84

0.18

5203

17707

(3035350) Ketones [Presence] in Urine by Test strip

5144

22005

2.19

307.65

3.8

2.4

0.00

estimate

1.34

1082

4090

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5479

2174

33.81

307.65

6.4

2.7

4.83

4.50

pmol/l

29.35

5141

1939

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2780

7632

3.08

307.65

2.5

1.5

0.89

1.35

mg/l

11.64

2077

5674

(3044889) 12 lead EKG panel

7360

31760

2.84

307.65

4.1

2.5

—

(3006315) Basophils [#/volume] in Blood

5915

19734

3.35

307.65

5.9

4.1

0.04

e9/l

0.36

5189

16868

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9041

45386

3.10

307.65

6.0

2.6

39.57

35.84

mmol/mol

230.16

8488

42037

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10448

59921

4.51

307.65

18.2

8.3

73.23

72.06

umol/l

3.61

10448

59866

(3019550) Sodium [Moles/volume] in Serum or Plasma

10256

53228

5.35

307.65

17.8

7.9

139.66

139.75

mmol/l

3.64

10078

51068

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5630

14577

4.46

307.65

6.6

4.4

1.22

1.21

mmol/l

1.18

5233

13214

(3013707) Erythrocyte sedimentation rate by Westergren method

8390

30984

4.63

307.65

4.5

2.2

11.20

9.66

mm/h

21.16

7921

28217

(3022217) INR in Platelet poor plasma by Coagulation assay

4626

14074

3.24

307.65

17.2

9.1

1.25

1.20

inr

3.13

1475

4150

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1462

1617

7.16

307.65

3.4

3.1

66.10

77.28

ng/l

4.97

1299

1411

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

4596

541

100.76

307.65

2.6

1.1

21.91

2.09

iu/l

1.41

2344

134

(3001604) Monocytes [#/volume] in Blood

5899

19699

3.34

307.65

5.9

4.1

0.56

0.55

e9/l

4.39

5180

16861

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2903

6812

3.70

307.65

4.1

2.3

1142.96

987.88

ng/l

1.56

2501

5769

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1695

4070

3.27

307.65

2.7

1.8

22.85

24.67

4.62

1441

3553

(3015377) Calcium [Moles/volume] in Serum or Plasma

4315

12686

3.27

307.65

3.0

4.0

2.34

2.35

mmol/l

8.51

3877

11443

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1836

4502

3.23

307.65

2.6

1.8

2.40

g/l

0.09

1691

4183

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2138

4048

4.35

307.65

1.3

1.1

6.95

1.79

u/ml

5.29

844

1725

(3037522) Nuclear Ab [Titer] in Serum

1932

3515

4.46

307.65

1.4

1.2

517.63

418.05

titre

1.25

455

512

(3013115) Eosinophils [#/volume] in Blood

6126

20679

3.40

307.65

6.2

4.3

0.19

0.18

e9/l

0.51

5464

17965

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2287

4605

4.13

307.65

1.3

1.1

23.85

14.93

iu/ml

4.59

699

1428

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3262

6375

4.67

307.65

2.2

1.6

184.38

184.71

u/l

0.00

3087

5940

(3019069) Monocytes/100 leukocytes in Blood

5604

19134

3.12

307.65

6.4

4.3

8.45

8.31

2.42

5240

17852

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5223

16534

3.29

307.65

2.5

1.8

75.50

75.60

nmol/l

0.09

4807

15205

(3018418) pH of Serum or Plasma

4092

9191

4.36

307.65

4.6

3.3

7.40

1.09

775

1657

(3018010) Neutrophils/100 leukocytes in Blood

5659

19837

3.04

307.65

6.0

4.0

56.68

56.38

1.05

5309

18595

(3024561) Albumin [Mass/volume] in Serum or Plasma

4593

15288

2.89

307.65

4.7

4.5

35.96

36.06

g/l

0.53

4268

14178

(3023103) Potassium [Moles/volume] in Serum or Plasma

10275

53519

5.38

307.65

18.0

8.0

3.94

3.92

mmol/l

4.59

10069

51193

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2120

5853

2.91

307.65

4.3

2.6

299.81

882.51

ng/l

5.57

1504

4024

(3013650) Neutrophils [#/volume] in Blood by Automated count

7213

24612

3.99

307.65

9.3

8.1

3.90

e9/l

0.04

6314

21102

(3021960) Folate [Moles/volume] in Serum or Plasma

2384

6817

2.85

307.65

1.5

1.3

19.92

20.43

nmol/l

0.90

2092

5909

(3009508) Creatinine [Moles/volume] in Urine

3082

6995

3.90

307.65

3.5

1.8

7.40

8.20

mmol/l

12.35

2620

6168

(40760892) CBC W Ordered Manual Differential panel - Blood

5643

18283

3.36

307.65

6.2

4.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2995

8766

2.91

307.65

2.4

1.9

2.77

2.75

mg/l

0.11

2594

7359

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10556

48973

10.45

307.65

13.3

3.4

1.69

2.27

mu/l

5.36

10182

45192

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1606

2567

4.97

307.65

2.3

2.6

377.61

400.92

nmol/l

3.77

1477

2389

(3031040) Bacteria [#/volume] in Urine by Automated count

6790

31983

2.25

307.65

4.8

3.0

785.60

857.13

e6/l

0.05

109

351

(3019309) Folate [Moles/volume] in Red Blood Cells

1869

4619

3.21

307.65

1.7

1.5

1110.26

1140.95

nmol/l

0.71

1486

3394

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1601

3374

3.72

307.65

5.6

4.6

1.05

1.02

mmol/l

2.72

1492

3164

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6242

16322

4.83

307.65

7.4

4.8

1.22

1.21

mmol/l

1.41

5354

13747

(3022096) Basophils/100 leukocytes in Blood

5447

18263

3.14

307.65

6.1

4.2

0.66

0.68

1.59

5070

16906

(3020682) Albumin/Creatinine [Ratio] in Urine

2910

5532

4.65

307.65

4.3

2.0

8.80

9.69

mg/mmol

0.35

1846

2982

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3484

11212

2.72

307.65

2.6

2.2

63.09

68.50

u/l

0.28

3237

10371

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9517

50908

3.13

307.65

14.6

7.2

85.81

87.03

ml/min/173m2

6.09

8177

39503

(3037467) Urinalysis macro (dipstick) panel - Urine

7089

32637

2.44

307.65

4.6

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8533

33111

4.44

307.65

8.5

6.1

77.31

77.43

u/l

0.08

8187

30942

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2018

5028

3.22

307.65

3.9

3.6

0.81

0.83

mmol/l

5.91

1900

4789

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3191

10231

2.67

307.65

1.4

1.2

1.79

2.11

u/ml

0.59

871

2894

(3007164) IgA [Mass/volume] in Serum or Plasma

2737

8643

2.62

307.65

1.5

1.3

2.18

2.19

g/l

0.11

1662

5502

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10544

61333

4.74

307.65

12.7

6.0

25.07

24.67

u/l

1.39

10335

58845

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5575

20525

2.81

307.65

6.1

6.4

10.61

11.80

umol/l

10.41

5306

19484

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3337

3603

8.86

307.65

1.4

1.2

199.19

158.37

iu/ml

4.16

1579

1401

(3022948) Iron [Moles/volume] in Serum or Plasma

1968

5012

3.14

307.65

2.6

1.8

13.72

14.62

umol/l

4.41

1837

4697

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9533

52284

2.92

307.65

4.5

2.8

5.87

5.43

mmol/l

180.73

8845

48388

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3984

11341

3.28

307.65

3.8

2.2

56.89

52.22

ng/l

0.09

2376

5710

(3002030) Lymphocytes/100 leukocytes in Blood

5753

20222

3.06

307.65

6.2

4.1

28.59

29.21

3.82

5395

18961

(3012516) Albumin [Mass/volume] in Urine

2785

5194

4.69

307.65

3.7

1.8

453.39

469.85

mg/l

0.05

1802

2771

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1769

4485

3.10

307.65

1.9

1.6

—

(40758558) Short blood count panel - Blood

3330

10562

2.73

307.65

7.3

6.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10356

39641

12.55

307.65

12.1

3.1

15.50

14.35

pmol/l

288.48

10028

36267

(3000850) Epithelial cells [#/volume] in Urine

2275

6960

2.63

305.29

2.6

2.0

6.53

6.66

e6/l

0.11

2046

6006

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3716

14271

2.24

302.76

3.3

2.9

29.73

32.74

u/l

1.32

3557

13694

(3026008) Bacteria identified in Urine by Culture

3151

11326

2.33

299.19

3.1

2.1

—

(40761511) CBC panel - Blood by Automated count

10367

61209

3.66

291.85

16.1

6.9

—

(36304419) Bacteria [Presence] in Urine

2871

10014

2.37

290.52

3.2

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

907

1614

4.21

286.84

2.3

2.9

65.93

65.96

g/l

0.02

828

1486

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1567

4070

2.98

283.13

2.9

2.1

30.25

29.94

0.88

1518

3959

(3002032) Base excess in Venous blood by calculation

1058

2167

3.68

276.98

3.8

2.9

1.84

1.83

mmol/l

0.02

903

1818

(3004588) Protein electrophoresis panel - Serum or Plasma

706

1049

4.98

275.90

2.0

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

596

755

5.80

274.69

1.3

1.1

0.61

0.52

u/ml

0.10

(3012544) pH of Venous blood

1083

2270

3.60

274.24

3.8

3.0

7.38

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1059

2186

3.66

274.10

3.8

2.9

5.86

5.79

kpa

1.08

1018

2117

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2047

6257

2.59

272.22

2.8

3.5

2.43

2.44

mmol/l

0.94

1749

5474

(3015736) pH of Urine

4196

17535

2.09

269.46

3.4

2.3

5.92

5.99

0.72

358

2140

(3026782) Osmolality of Urine

2173

6891

2.51

267.60

2.9

2.2

526.46

551.32

mosm/kgh2o

5.00

1863

5734

(3044640) Blood type and Crossmatch panel - Blood

3635

14481

2.13

262.99

2.4

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1212

2826

3.26

260.75

1.8

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

2805

10122

2.26

258.19

4.4

3.3

91.17

93.13

3.35

2735

9895

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1217

2864

3.23

257.88

1.8

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5100

23193

2.00

256.57

2.7

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

274

135

14.59

243.81

1.4

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

8958

50429

2.26

243.07

20.6

9.3

14.68

14.84

0.31

8850

49143

(3005719) IgG [Mass/volume] in Serum or Plasma

939

1964

3.58

237.44

2.5

2.4

10.31

10.82

g/l

2.65

852

1794

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

464

527

6.41

236.50

2.0

1.3

—

(40768797) Stomach Pathology biopsy report

1602

4633

2.67

235.02

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1068

2451

3.28

234.66

3.9

3.0

1.22

1.23

mmol/l

2.17

940

2090

(3000475) Leukocytes [#/volume] in Synovial fluid

241

17.82

234.33

1.8

1.2

9095.58

21739.23

e6/l

0.56

175

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

248

107

16.63

234.26

1.7

1.2

17.04

13.48

pmol/l

3.85

223

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

262

128

14.70

234.04

2.4

1.9

64.06

91.87

ug/min

0.27

169

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9705

56903

2.52

231.78

4.9

3.2

2.80

2.98

mmol/l

71.62

9100

53239

(3021788) Differential panel - Synovial fluid

200

24.65

218.36

1.6

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9575

56219

2.38

217.59

4.5

3.0

4.67

4.92

mmol/l

102.42

9026

52930

(3024354) Oxygen [Partial pressure] in Venous blood

844

1757

3.57

214.30

3.4

2.5

4.59

4.62

kpa

0.13

802

1693

(3003396) Base excess in Arterial blood by calculation

1137

2866

2.99

213.35

8.4

6.7

0.99

0.70

mmol/l

1.44

898

2271

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

462

584

5.76

212.82

1.8

1.2

1.19

1.15

g/l

1.38

433

549

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

452

560

5.87

212.30

1.8

1.2

0.23

g/l

0.72

425

521

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1133

2860

2.98

212.03

8.4

6.7

5.05

5.07

kpa

0.31

1082

2729

(3027801) Oxygen [Partial pressure] in Arterial blood

1132

2857

2.99

211.90

8.4

6.7

12.39

14.17

kpa

16.66

1082

2726

(3009445) Proteinase 3 Ab [Units/volume] in Serum

559

851

4.81

211.84

1.4

1.2

12.76

7.75

u/ml

0.33

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1813

5869

2.40

209.01

2.8

2.2

1.08

1.27

e6/l

0.63

1027

2946

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9503

55877

2.31

208.94

4.4

3.0

1.47

1.55

mmol/l

76.72

8907

52545

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7071

37425

1.89

208.76

3.3

2.2

42.70

35.61

u/l

12.29

6717

35533

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

605

1002

4.43

207.78

3.6

3.4

5.14

5.06

kpa

1.18

572

938

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

457

586

5.67

207.54

1.3

1.1

50.26

9.28

u/ml

1.99

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2785

10801

2.08

207.50

2.4

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

903

2011

3.34

207.09

2.3

2.2

18.41

23.26

au/ml

0.81

295

(3014576) Chloride [Moles/volume] in Serum or Plasma

1316

3662

2.73

206.31

8.3

6.3

104.49

105.03

mmol/l

3.57

1316

3662

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

910

2043

3.32

206.08

4.0

2.3

241.32

184.86

ng/l

1.34

830

1866

(3027945) Reticulocytes/100 erythrocytes in Blood

1181

3102

2.87

205.87

2.5

2.4

1.70

1.63

1.77

1051

2757

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9192

53477

2.18

203.89

4.0

2.7

1.25

1.14

mmol/l

48.82

8567

50072

(3009343) pH of Capillary blood

595

996

4.38

201.64

3.6

3.4

7.41

7.42

0.85

129

(3019225) pH of Specimen

1157

3040

2.87

201.37

4.5

3.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

579

961

4.41

198.21

3.5

3.3

1.72

1.64

mmol/l

0.14

421

679

(3016502) Oxygen saturation in Arterial blood

1014

2493

3.04

197.98

8.9

7.2

95.37

96.46

4.51

973

2400

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3933

17529

1.89

194.79

3.9

2.4

—

(3042936) Bacteria identified in Isolate by Culture

1437

4302

2.55

194.51

2.2

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

953

2282

3.11

194.33

10.1

5.3

9.36

7.99

mmol/l

6.73

913

2196

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

610

1083

4.13

191.98

2.2

38.26

41.65

u/l

3.09

546

992

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

819

1796

3.38

191.95

1.3

1.2

42.49

45.27

au/ml

0.11

161

(3009542) Hematocrit [Volume Fraction] of Blood

10781

68140

4.26

191.59

26.3

10.7

40.36

40.95

2.01

10303

64178

(3017181) Myelocytes/100 leukocytes in Blood

954

2329

3.05

188.18

3.9

3.5

1.05

1.06

0.01

297

767

(3007461) Platelets [#/volume] in Blood

10786

68306

4.23

187.69

26.2

10.7

260.22

255.37

e9/l

12.65

10641

65839

(3000991) Gas panel - Venous blood

962

2365

3.03

187.52

9.7

7.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2770

11079

2.01

186.92

1.7

1.5

1.35

1.23

mmol/l

10.21

2308

9639

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

404

510

5.74

186.17

1.3

1.1

18.56

6.43

u/ml

0.93

(3035941) MCH [Entitic mass]

10789

68415

4.22

185.03

26.0

10.6

30.05

30.13

4.84

10718

67168

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

824

1861

3.28

184.33

2.4

1.9

10.02

11.27

ug/l

0.39

714

1652

(3026361) Erythrocytes [#/volume] in Blood

10789

68450

4.20

183.83

26.1

10.7

4.52

e12/l

0.27

10609

65829

(3024731) MCV [Entitic volume]

10788

68446

4.19

183.60

26.0

10.6

90.39

90.25

2.37

10717

67195

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

298

269

7.97

183.42

1.5

1.2

601.69

428.83

mg/l

1.33

281

250

(3010813) Leukocytes [#/volume] in Blood

10788

68464

4.18

182.99

26.2

10.7

6.66

6.48

e9/l

11.50

10613

65786

(3000963) Hemoglobin [Mass/volume] in Blood

10791

68510

4.19

182.50

26.3

10.7

135.20

135.70

g/l

3.69

10717

67259

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

397

503

5.71

182.26

1.3

1.1

11.82

2.72

u/ml

0.80

(3011397) Hemoglobin [Presence] in Urine by Test strip

2393

9148

2.07

182.00

3.8

2.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

965

2428

2.96

180.56

8.7

6.1

1.27

1.26

mmol/l

0.07

940

2360

(3021440) Promyelocytes/100 leukocytes in Blood

909

2213

3.05

179.90

3.9

3.5

0.07

0.12

0.67

254

663

(3007853) Bacteria identified in Skin by Aerobe culture

1298

3840

2.56

179.18

1.9

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

753

1635

3.40

178.87

1.8

1.9

1.23

1.45

g/l

2.11

689

1494

(3025159) Blasts/100 leukocytes in Blood

874

2115

3.07

174.58

3.9

3.5

0.05

0.67

1.69

220

575

(3002179) Metamyelocytes/100 leukocytes in Blood

872

2111

3.06

174.05

3.7

3.5

0.79

0.71

0.25

263

672

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

277

246

8.09

172.57

1.5

1.4

1133.82

222.40

e6/l

0.86

225

192

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

385

501

5.56

172.08

2.3

2.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

277

247

8.05

172.05

1.4

1.3

53.58

13.31

e6/l

1.03

210

185

(3004119) Hemoglobin [Mass/volume] in Venous blood

666

1372

3.56

170.89

3.4

2.5

133.24

129.69

g/l

3.03

648

1343

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1245

3704

2.53

169.42

5.3

4.7

233.57

248.50

u/l

2.06

1177

3552

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1705

5854

2.24

168.88

3.1

2.2

3.30

2.95

e6/l

0.61

932

2933

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

801

1878

3.15

168.42

1.6

1.4

—

(3008898) HLA-B27 [Presence]

487

805

4.40

167.23

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

375

491

5.52

166.54

3.6

5.7

99.76

84.80

u/ml

0.18

133

174

(3002173) Hemoglobin [Mass/volume] in Arterial blood

934

2423

2.86

165.12

9.5

7.3

122.91

120.44

g/l

2.61

904

2352

(3029937) Albumin [Presence] in Urine by Test strip

2715

11193

1.93

164.85

4.2

2.4

0.00

estimate

0.15

1016

3860

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

445

692

4.66

164.19

1.5

454.74

165.26

titre

0.85

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

264

235

8.06

164.17

1.4

1.2

3.78

3.46

mmol/l

3.69

251

217

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

319

366

6.27

160.75

1.2

1.1

0.99

8.15

u/ml

0.49

(3044941) Cell count panel - Synovial fluid

162

18.32

159.55

1.6

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

839

2089

2.97

159.26

2.3

2.6

71.58

67.05

e9/l

2.35

618

1507

(3048689) Calprotectin [Mass/mass] in Stool

1608

5527

2.22

158.06

2.1

2.6

114.29

122.00

ug/g

0.34

1245

4361

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

415

630

4.77

157.34

2.0

2.1

7.48

7.01

g/l

4.34

375

569

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

630

4.76

156.53

2.0

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

413

629

4.75

156.00

2.0

2.1

3.66

3.68

g/l

0.09

373

568

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

390

577

4.88

152.15

2.9

2.1

376.20

376.54

ug/l

0.00

359

548

(3022313) Gas panel - Capillary blood

424

677

4.53

151.61

3.8

3.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

601

1251

3.51

151.60

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

250

230

7.79

151.58

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

1175

3580

2.46

151.33

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

394

599

4.75

149.08

3.7

3.8

24.76

24.72

mmol/l

0.08

369

552

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

356

496

5.18

148.20

1.2

1.1

43.39

25.23

u/ml

0.86

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

394

603

4.72

147.95

2.0

2.1

2.94

2.93

g/l

0.06

354

541

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

521

1000

3.79

147.40

3.3

2.1

1.21

1.24

0.16

516

995

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

651

1463

3.26

146.06

1.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

587

1240

3.46

144.78

4.2

3.2

24.21

24.28

mmol/l

0.18

575

1216

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1074

3202

2.50

144.48

3.2

2.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

121

34.37

144.48

1.7

1.1

54.10

56.89

0.10

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

599

4.64

141.83

2.0

2.1

9.66

10.50

g/l

2.41

344

533

(3019150) Specific gravity of Urine by Refractometry

2197

8839

1.93

140.36

4.2

2.4

1.02

kg/l

0.50

369

1463

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

365

549

4.80

139.73

2.0

2.3

0.42

1.28

g/l

2.86

314

474

(3027273) Bicarbonate [Moles/volume] in Venous blood

503

979

3.73

139.51

3.2

2.5

25.39

25.20

mmol/l

0.55

486

946

(40768804) Tissue Pathology biopsy report

4507

22489

1.68

139.41

2.1

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1347

4527

2.24

138.54

2.6

2.7

7.19

9.54

umol/l

3.32

1150

3987

(3027456) Digoxin [Moles/volume] in Serum or Plasma

260

286

6.52

136.00

3.3

2.9

0.85

0.80

nmol/l

0.79

203

213

(3019060) Gas panel - Arterial blood

609

1382

3.22

134.36

4.2

4.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

327

477

4.93

129.48

2.5

3.9

81.57

35.20

mg/l

0.60

269

404

(3034860) Kappa light chains.free [Mass/volume] in Serum

326

479

4.90

128.05

2.5

3.9

39.11

47.53

mg/l

0.85

268

406

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

371

612

4.37

127.46

1.4

1.3

9.27

3.29

iu/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

331

497

4.79

126.91

1.9

2.2

0.01

0.05

g/l

0.59

298

453

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

334

509

4.72

125.93

1.9

2.1

37.88

38.48

g/l

0.84

294

447

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

404

721

4.05

125.76

2.3

2.2

11.03

10.23

mg/l

1.19

376

685

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

316

461

4.93

125.10

2.5

3.9

1.12

1.89

ratio

1.34

(3004616) Nuclear Ab [Presence] in Serum

204

188

7.75

123.50

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

332

513

4.66

123.20

2.1

1.9

5.10

5.93

mmol/24h

3.39

296

464

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

377

648

4.20

123.10

1.6

1.5

0.04

3.42

iu/ml

0.51

144

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

312

460

4.87

122.07

1.9

2.2

0.01

0.00

g/l

0.13

280

417

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

190

163

8.31

121.38

2.0

2.4

0.83

0.76

nmol/l

0.49

154

150

(3041096) Erythrocytes [Presence] in Urine by Automated

2894

13184

1.73

121.10

3.4

2.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

515

1122

3.33

120.94

1.8

1.7

1.50

1.37

g/l

2.00

436

953

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

197

179

7.85

120.56

1.1

137.33

12.91

iu/ml

1.80

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

306

456

4.82

118.30

1.9

2.2

0.00

g/l

-0.00

280

417

(3001019) Free T4 and TSH panel - Serum or Plasma

1240

4316

2.15

115.88

2.3

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

579

1413

2.98

112.99

11.7

8.7

24.43

24.22

mmol/l

0.81

568

1365

(3008152) Bicarbonate [Moles/volume] in Arterial blood

563

1359

3.01

111.92

6.4

6.1

24.43

24.42

mmol/l

0.00

527

1284

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1101

3720

2.20

110.50

2.4

2.3

40.62

43.35

u/l

0.21

942

3260

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

429

882

3.51

109.81

4.1

2.9

48.77

46.09

1.19

421

870

(3005322) IgE [Units/volume] in Serum or Plasma

864

2649

2.40

108.40

1.4

1.2

159.41

255.09

u/ml

3.10

816

2471

(3000494) Fungus identified in Specimen by Culture

1248

4500

2.07

105.94

1.5

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

621

1639

2.76

105.25

1.1

2.97

9.14

u/ml

—

(3017732) Neutrophils [#/volume] in Blood

861

2673

2.37

105.00

2.6

2.3

4.64

4.20

e9/l

0.77

722

2298

(40761535) Cells panel - Urine sediment

746

2166

2.52

104.93

3.8

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

22.91

103.62

1.6

1.1

36.77

30.71

0.32

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

242

329

5.26

103.28

4.8

7.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

126

12.09

102.37

1.0

1.1

7.29

0.10

nmol/l

0.72

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

385

797

3.48

97.49

4.6

3.2

0.37

0.33

u/ml

1.09

218

415

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

642

1796

2.60

97.18

1.6

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

196

233

6.00

95.51

1.2

1.1

54.94

17.72

u/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

989

3392

2.15

95.05

2.3

2.2

0.22

g/l

0.53

934

3216

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

214

281

5.44

94.65

1.6

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

572

1541

2.69

93.10

11.2

8.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

251

395

4.54

91.14

1.7

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

409

922

3.20

90.82

3.1

2.6

—

(3016018) Differential panel - Cerebral spinal fluid

148

139

7.57

88.30

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1082

3955

2.02

87.70

7.3

4.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

192

245

5.59

87.40

1.3

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

231

351

4.70

87.34

2.7

3.9

—

(4200892) Spirometry reversibility

730

2284

2.33

87.05

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

330

672

3.53

85.56

1.4

1.3

278.08

282.34

ug/g

0.11

198

371

(3024928) Oxygen saturation in Venous blood

285

532

3.84

83.49

3.4

2.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

249

419

4.25

83.41

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

123

8.91

82.83

1.7

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

15.17

82.00

1.3

1.0

92498.25

56704.55

e6/l

0.24

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

14.16

81.16

1.4

1.0

5.96

5.05

u/l

0.56

(3000492) Spirometry study

1178

4552

1.91

81.16

1.5

1.3

—

(4146454) Self-monitoring of blood glucose

14.48

80.25

3.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

101

11.54

80.07

1.1

—

(3020891) Body temperature

366

840

3.13

78.90

4.7

3.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

256

462

3.96

78.44

1.5

0.76

0.80

g/l

0.22

193

353

(3023410) Appearance of Cerebral spinal fluid

135

134

7.15

77.08

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

371

871

3.06

77.04

2.2

1.8

0.89

2.31

ug/l

1.88

326

785

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

104

10.24

76.79

1.2

1.1

38.60

26.30

mg/l

1.47

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

216

349

4.41

76.04

1.2

1.3

0.16

0.14

nmol/l

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

238

416

4.09

76.01

3.5

2.7

24.96

24.66

mmol/l

0.39

232

402

(1616796) Gas panel - Central venous blood

247

446

3.96

75.63

3.2

2.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

218

358

4.34

75.25

1.2

1.3

0.55

0.60

nmol/l

0.86

209

344

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

107

9.36

74.61

1.5

1.1

2.20

1.89

mmol/l

1.44

100

(1002224) Polysomnography panel

500

1411

2.56

74.11

1.1

1.0

—

(3022145) Colonoscopy Study observation

1180

4701

1.85

73.69

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

282

574

3.52

73.15

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2502

12245

1.56

72.64

1.7

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

386

963

2.88

72.19

1.3

1273.33

1005.90

titre

0.34

(3017143) Hepatitis C virus Ab [Presence] in Serum

1475

6327

1.74

71.92

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

10.06

71.61

1.1

237.54

194.75

mg/l

1.30

(3020961) Endomysium IgA Ab [Titer] in Serum

707

2374

2.17

71.01

1.2

1.1

167.87

246.12

titre

0.60

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

195

308

4.51

70.53

1.2

—

nmol/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

111

8.20

70.53

1.1

1.0

—

(3010421) pH of Blood

294

631

3.34

70.46

3.3

2.7

7.43

7.42

0.88

271

588

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

196

312

4.47

70.24

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

558

1706

2.37

69.79

2.4

2.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

170

241

5.02

69.45

1.4

1.2

0.34

0.42

g/l

2.08

122

163

(3028192) IgG subclass 2 [Mass/volume] in Serum

170

242

5.00

69.14

1.4

1.2

2.91

3.24

g/l

1.28

122

165

(3007566) Smooth muscle Ab [Titer] in Serum

386

987

2.81

69.06

1.3

1.4

120.57

139.01

titre

0.15

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

12.03

69.00

1.1

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

169

244

4.93

67.69

1.4

1.2

6.42

6.82

g/l

0.76

119

167

(4062490) Immunoglobulin typing, IgG

168

243

4.92

67.16

1.5

1.2

—

(40761536) Microorganisms panel - Urine sediment

1006

3919

1.88

67.04

3.9

2.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1162

4763

1.80

65.81

4.4

3.1

32.97

32.81

0.19

883

3193

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.21

65.57

1.2

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

475

1388

2.47

65.46

2.0

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

289

646

3.20

65.00

1.4

—

(3012501) Base excess in Blood by calculation

256

532

3.44

64.42

3.4

2.8

2.27

2.53

mmol/l

0.73

169

324

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

125

140

6.33

64.40

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

125

141

6.29

63.99

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

141

6.29

63.99

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

198

345

4.09

63.52

1.6

1.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

124

140

6.28

63.43

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

124

141

6.24

63.02

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

370

974

2.73

62.72

4.4

4.5

1.74

1.66

0.48

343

899

(40759836) Histone Ab [Presence] in Serum by Immunoblot

123

140

6.23

62.46

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

365

958

2.73

62.22

4.5

0.90

0.91

0.03

339

886

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

13.94

62.21

1.1

1.0

1.02

0.99

u/l

0.14

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7241

44319

1.42

61.97

3.5

3.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

225

440

3.65

61.84

3.6

3.0

8.36

8.55

kpa

0.69

218

426

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

766

2797

1.99

61.50

2.8

2.2

67.35

74.84

ml/min/173m2

5.12

332

935

(3023183) Ammonium ion [Moles/volume] in Plasma

228

455

3.57

60.89

2.4

2.6

30.95

38.78

umol/l

4.15

204

421

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

272

610

3.19

60.86

6.0

3.9

241.51

580.37

iu/ml

1.60

(3013139) Helicobacter pylori Ag [Presence] in Stool

783

2894

1.97

60.73

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

391

1079

2.60

60.52

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

260

569

3.26

60.47

2.0

1.9

131.25

130.94

g/l

0.06

158

432

(3045414) Leukocytes [Presence] in Urine

496

1536

2.33

60.19

2.0

1.5

—

(3025941) Bacteria identified in Stool by Culture

683

2413

2.05

59.98

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

273

625

3.12

59.09

1.4

1.5

—

(3011985) Renin [Units/volume] in Plasma

201

377

3.80

58.55

2.2

1.7

77.59

49.55

mu/l

1.22

173

342

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

9.71

57.94

1.6

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

539

1763

2.21

57.54

2.9

2.0

0.17

0.32

e6/l

3.07

521

1703

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

425

1252

2.44

57.52

1.9

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

307

767

2.86

57.26

1.8

1.4

—

(3036489) Thrombin time

453

1379

2.36

57.10

3.0

1.8

21.55

21.23

0.37

403

1178

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

14.35

55.99

1.2

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

990

4055

1.79

55.78

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

17.50

55.23

1.3

0.51

0.53

ug/l

0.04

(3044927) Protein electrophoresis panel - Urine

102

108

6.69

55.23

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

301

760

2.83

55.09

2.6

2.4

—

(3004775) Volume in Urine collected for unspecified duration

9.77

54.60

2.2

1.7

660.84

730.49

0.51

(3022621) pH of Urine by Test strip

711

2636

1.96

54.52

3.2

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

170

298

4.05

54.17

1.2

73.82

67.59

u/l

0.25

152

269

(3003338) MCHC [Mass/volume]

8455

53711

1.44

53.90

22.4

9.3

331.83

332.82

g/l

20.21

8408

53169

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

156

263

4.21

52.22

7.6

6.1

11.41

10.99

mg/l

0.49

146

248

(3047181) Lactate [Moles/volume] in Blood

314

839

2.68

51.75

4.7

4.9

1.33

1.26

mmol/l

0.54

278

735

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

250

591

3.02

51.33

1.3

—

(3021901) Oxygen saturation in Capillary blood

166

298

3.96

51.30

3.0

2.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

250

592

3.01

51.19

3.0

3.6

58.01

56.69

0.79

250

592

(3003181) Sodium [Moles/volume] in Urine

178

341

3.71

50.40

1.4

1.3

66.97

63.51

mmol/l

0.39

147

253

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

409

1263

2.32

49.90

1.4

1.3

—

(3000330) Specific gravity of Urine by Test strip

500

1699

2.12

48.48

3.3

2.5

—

(40767503) Oxygen content in Capillary blood by calculation

205

447

3.26

48.01

2.2

1.8

16.59

16.50

0.08

171

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

9.42

47.75

1.3

1.2

51.75

85.33

—

(3037121) Protein [Mass/volume] in Urine

365

1098

2.38

47.20

3.0

3.6

0.32

0.20

g/l

1.96

165

557

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

242

595

2.90

46.47

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

242

595

2.90

46.47

1.3

1.2

—

(40768443) Skin Pathology biopsy report

505

1755

2.07

46.17

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

210

477

3.13

46.09

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

941

4007

1.71

45.97

1.4

1.3

29.26

28.34

iu/l

0.33

801

3456

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

210

478

3.13

45.94

1.4

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

8.36

45.93

1.8

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

236

577

2.91

45.77

1.4

1.2

4.27

2.07

u/ml

1.29

106

177

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

12.13

44.92

2.5

1.1

155.14

6.31

ug/min

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

197

439

3.19

44.60

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

537

2.96

44.41

1.4

1.2

5.53

4.19

u/ml

0.73

104

237

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

198

446

3.16

44.07

2.8

2.4

451.67

992.66

u/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

140

249

3.99

43.85

2.2

2.6

18.36

20.98

nmol/l

1.87

134

238

(3014765) Yersinia sp identified in Stool by Organism specific culture

372

1175

2.27

43.09

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

373

1185

2.25

42.63

1.2

1.1

—

(3024263) Appearance of Synovial fluid

9.69

42.21

1.7

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

428

1446

2.12

42.08

1.1

3.68

6.24

u/ml

1.09

272

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

137

248

3.92

41.94

1.1

1.2

93.50

289.25

titre

2.11

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

368

1173

2.25

41.73

1.2

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

433

3.12

41.52

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

156

313

3.54

41.44

5.2

6.4

380.76

407.01

umol/l

1.24

126

266

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

166

351

3.36

40.81

1.4

1.5

331.73

389.91

pmol/l

0.89

145

311

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

157

321

3.47

40.59

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1301

6193

1.54

40.24

1.6

1.5

1.37

1.28

4.53

1158

5658

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

218

549

2.83

40.16

1.5

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

163

345

3.35

40.02

1.7

1.5

1.54

1.75

mmol/l

2.17

158

339

(3002256) Pathology report gross observation

1435

6987

1.51

39.94

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

134

251

3.78

39.22

1.4

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

228

599

2.71

38.86

1.6

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

16.59

37.90

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

442

1580

2.01

37.42

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

196

485

2.87

37.28

3.4

2.2

1.51

1.42

mmol/l

0.51

186

472

(3016750) Collection duration of Urine

8.03

36.48

2.0

1.8

511.11

497.42

min

0.34

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

163

367

3.15

36.37

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.75

36.14

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

106

5.40

36.11

1.6

1.7

2.34

4.18

nmol/l

0.38

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

150

323

3.29

35.91

1.5

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

458

1683

1.95

35.87

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

150

324

3.28

35.74

1.5

1.3

—

(3023419) Bacteria identified in Sputum by Culture

144

303

3.37

35.72

2.6

2.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

131

259

3.58

35.60

6.8

2.4

7.55

5.90

mmol/l

5.30

107

202

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

681

2845

1.73

35.39

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

142

298

3.38

35.36

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

300

942

2.27

35.26

2.6

1.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

379

1312

2.07

34.99

3.4

2.1

93.76

89.04

3.64

363

1252

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

8.28

34.77

1.1

1043.27

85.92

ng/l

0.58

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

210

563

2.65

34.48

1.2

1.1

112.98

112.74

0.03

194

493

(3038515) Glucose [Moles/volume] in Venous blood

182

452

2.86

34.43

3.6

2.3

7.36

6.38

mmol/l

4.09

174

442

(3006653) Thiamine [Moles/volume] in Blood

6.46

34.35

1.2

1.5

135.47

131.50

nmol/l

0.18

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

361

1236

2.09

34.31

3.9

2.0

178.90

177.32

0.13

345

1166

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

322

3.21

33.70

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

236

683

2.46

33.23

1.5

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

156

4.31

32.98

1.6

2.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

220

621

2.52

32.63

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

326

3.15

32.48

2.4

1.6

22.00

31.65

mg/l

1.00

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

119

235

3.59

32.43

1.4

1.7

—

(3018572) Chloride [Moles/volume] in Blood

207

572

2.57

32.06

5.5

6.1

105.04

105.06

mmol/l

0.01

183

507

(3039000) Anion gap in Blood

207

572

2.57

32.06

5.5

6.1

11.77

11.10

mmol/l

1.46

183

507

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

106

195

3.85

31.86

2.0

1.7

—

(3011648) Oxygen content in Venous blood

116

228

3.60

31.83

2.3

2.1

11.51

11.11

0.40

116

228

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

153

360

3.01

31.81

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

455

1743

1.87

31.48

1.4

1.3

12.02

9.67

u/l

2.63

375

1429

(3005988) Vibrio sp identified in Specimen by Organism specific culture

152

359

3.00

31.40

1.3

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

118

237

3.53

31.40

1.0

303.99

299.98

mg/l

0.18

108

220

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

154

368

2.97

31.19

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

174

3.98

30.88

2.4

0.96

0.89

g/24h

0.11

(3025468) Yersinia sp identified in Specimen by Organism specific culture

151

359

2.98

30.86

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

151

359

2.98

30.86

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

342

1196

2.04

30.76

2.5

2.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

171

438

2.77

30.64

3.2

3.3

1.07

1.82

2.24

153

389

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

152

4.19

30.22

1.2

1.1

78.65

75.85

u/l

0.12

137

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

153

4.16

29.98

1.2

1.1

19.20

13.95

u/l

0.51

137

(3024522) Salmonella sp identified in Specimen by Organism specific culture

150

362

2.94

29.89

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

173

3.92

29.68

1.5

1.6

6.20

5.74

u/l

0.11

141

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

296

993

2.12

29.68

1.4

1.3

29.82

26.38

u/l

0.83

240

833

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

273

890

2.18

29.40

1.5

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

7.69

29.29

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

285

3.18

29.16

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

441

1715

1.84

29.11

1.6

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

207

600

2.45

29.11

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

120

257

3.31

29.05

2.3

2.0

1.21

1.18

e9/l

0.12

107

223

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

102

198

3.64

28.53

1.3

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

158

404

2.77

28.43

1.2

1.1

91.40

92.11

0.11

152

371

(44816559) Phosphatidylethanol [Mass/volume] in Blood

228

699

2.32

28.38

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

367

1355

1.93

28.37

3.7

2.1

3.55

3.60

g/l

0.22

349

1290

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

270

891

2.16

28.23

3.1

3.0

1.60

1.18

mg/l

11.57

247

836

(3017704) Immunofixation for Urine

5.47

28.10

1.7

1.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

100

195

3.63

27.80

2.0

1.5

134.10

126.03

0.43

185

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

6.06

27.51

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

270

901

2.13

27.46

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

109

228

3.38

27.38

2.8

1.9

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

13.65

26.88

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

13.65

26.88

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

13.65

26.88

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

13.65

26.88

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

216

663

2.31

26.83

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

4.99

26.79

2.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

7.38

26.61

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

254

839

2.15

26.52

1.3

1.2

300.62

252.51

u/ml

1.28

177

574

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

256

850

2.14

26.39

1.5

1.3

132.84

105.50

u/ml

0.79

184

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

157

3.87

26.19

1.1

1.4

22.94

23.57

u/l

0.03

136

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

267

905

2.10

26.12

1.5

1.3

17.28

20.95

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

176

500

2.50

25.85

1.1

1.48

g/l

0.00

162

462

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

135

334

2.86

25.82

1.1

1.5

—

titre

—

(3002079) Sodium [Moles/time] in 24 hour Urine

143

4.00

25.77

1.2

1.3

165.18

161.25

mmol/24h

0.13

143

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

190

561

2.40

25.73

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

152

403

2.67

25.61

1.3

26.86

41.18

u/l

0.60

139

353

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

13.21

25.59

1.4

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

140

356

2.79

25.50

2.6

2.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

164

3.75

25.39

1.1

1.4

79.80

101.03

u/l

0.85

150

(1175426) CD3 cells/100 lymphocytes in Blood

100

208

3.40

25.36

2.0

1.6

72.65

71.67

0.23

203

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

198

601

2.34

25.25

1.2

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

102

216

3.34

25.18

3.7

3.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

117

271

3.06

25.07

1.3

1.2

0.26

2.02

u/ml

2.69

144

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

217

3.32

25.01

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

217

3.32

25.01

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

217

3.32

25.01

1.3

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

112

253

3.13

25.00

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

110

246

3.16

24.95

1.5

1.6

285.57

279.86

mosm/kgh2o

1.37

209

(1761482) Bacteria [#/volume] in Urine by Culture

241

800

2.14

24.88

4.0

2.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

293

1051

1.98

24.64

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

605

2693

1.61

24.61

1.6

301.83

328.84

mu/l

0.91

538

2394

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

308

1126

1.95

24.54

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

184

549

2.38

24.38

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

113

262

3.05

24.18

2.5

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

13.15

23.82

1.5

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

207

3.31

23.70

2.0

1.6

14.25

13.73

0.19

202

(40757494) Bilirubin.total [Moles/volume] in Blood

4.93

23.66

2.4

1.9

16.03

56.04

umol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

429

1765

1.74

23.50

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

286

2.92

23.44

3.6

3.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

11.12

23.36

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

3.80

23.23

1.4

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.81

23.07

1.7

2.2

119.20

147.14

umol/l

0.24

(3024891) Influenza virus A+B Ag [Presence] in Specimen

329

1259

1.86

22.89

1.1

—

(3051651) Icteric interference index of Serum or Plasma

219

3.20

22.89

4.3

3.3

—

(3042733) HLA Ab [Presence] in Serum

5.74

22.85

5.3

4.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

110

261

2.98

22.68

3.0

3.6

55.20

54.99

0.03

215

(3051611) Lipemic interference index of Serum or Plasma

132

348

2.69

22.54

4.0

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

152

3.67

22.46

1.1

1.2

9.25

10.11

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

211

693

2.16

22.41

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

10.75

22.14

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

111

269

2.92

22.08

14.0

11.5

0.65

0.62

mmol/l

0.91

101

244

(4034850) Laboratory test

332

1292

1.83

21.92

12.1

5.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

116

4.08

21.91

24.8

4.3

2032.43

1858.67

mg/l

0.02

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

186

3.34

21.85

2.4

2.2

0.22

0.23

e9/l

0.10

153

(3004451) EKG impression Narrative

4.70

21.72

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

177

549

2.29

21.56

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

722

3454

1.50

21.33

2.3

2.2

6012.40

6430.24

u/l

0.12

289

1644

(3023511) Choriogonadotropin [Units/volume] in Urine

391

1612

1.73

21.28

1.4

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

190

3.27

21.16

2.4

2.2

520.28

515.01

e6/l

0.03

156

(3017446) Testosterone [Moles/volume] in Serum or Plasma

634

2962

1.53

20.93

2.3

1.8

10.90

11.99

nmol/l

2.16

567

2711

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

198

652

2.15

20.92

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

219

752

2.07

20.80

1.2

1.1

5.37

10.33

au/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

158

3.49

20.65

2.5

1.8

16.44

47.82

mg/l

1.04

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

5.64

20.63

1.0

38.75

28.03

ng/l

1.11

(3016038) Potassium [Moles/volume] in Urine

136

3.69

20.35

1.2

33.35

40.54

mmol/l

1.41

120

(3019977) pH of Arterial blood

4.25

20.34

2.8

1.7

7.41

7.42

0.28

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

674

3211

1.51

20.31

2.7

3.7

38.50

47.67

u/ml

0.69

647

3147

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.05

20.15

2.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

137

3.66

20.15

1.2

33.33

92.31

titre

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

158

3.44

20.01

1.5

1.4

29.64

20.36

u/ml

0.55

(3014271) Vancomycin [Susceptibility]

5.10

19.93

3.0

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.01

19.75

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.01

19.75

1.1

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

319

2.64

19.74

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

240

2.92

19.73

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

241

2.90

19.59

1.0

—

(40768446) Kidney Pathology biopsy report

5.59

19.53

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

5.87

19.51

8.6

19.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

188

625

2.13

19.43

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

5.41

19.39

1.0

645.76

906.68

ng/l

1.99

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

277

1060

1.86

19.33

1.7

1.4

49.31

48.92

nmol/l

0.06

271

1046

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.25

19.33

1.5

91.25

300.46

nmol/24h

0.51

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

174

3.25

19.06

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

151

462

2.31

19.03

2.3

3.6

4.03

4.90

nmol/l

0.48

140

450

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

181

598

2.15

19.01

2.0

1.6

179.75

190.60

pmol/l

0.56

159

570

(3000012) Reticulocyte production index

123

342

2.54

19.00

1.9

2.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

5.38

18.84

1.0

280.35

259.27

ng/l

0.16

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.42

18.82

1.5

2735.60

3545.00

u/ml

—

(3029075) Extractable nuclear Ab panel - Serum

4.28

18.82

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

141

3.50

18.72

1.9

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.17

18.58

29.5

25.2

116.95

139.14

ug/l

1.35

(21494755) Public health laboratory ask at order entry panel

1029

9511

0.74

18.28

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

+∞

18.10

1.6

0.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

102

265

2.72

18.00

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

147

462

2.25

17.46

1.6

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

133

400

2.35

17.46

1.6

1.3

33.28

35.71

g/l

1.24

119

361

(3042631) Mycobacterium sp identified in Specimen

112

311

2.55

17.39

2.4

2.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

228

2.82

17.18

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

232

2.80

17.16

2.3

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

621

3012

1.48

17.13

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

5.55

17.12

1.2

1.1

2.19

6.01

pmol/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

7.29

17.04

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

262

2.67

16.90

1.1

386.43

405.38

nmol/l

0.39

249

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

111

3.69

16.71

1.5

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

240

2.74

16.65

1.9

2.4

95.45

95.33

0.01

219

(37021550) Renin [Units/volume] in Plasma --upright

4.94

16.47

1.4

1.6

75.78

60.90

mu/l

0.18

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

788

7472

0.72

16.40

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

173

3.06

16.33

1.4

1.2

1.34

1.43

promille

0.19

138

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

227

2.77

16.29

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

114

3.59

16.11

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

205

2.86

16.10

1.6

1.7

12.21

7.48

ug/l

0.44

185

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

225

2.76

16.04

1.1

1.07

1.06

ratio

0.29

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

299

2.51

15.98

1.5

1.2

4.64

6.13

umol/l

3.78

101

281

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

8.00

15.75

1.1

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

116

3.53

15.73

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

123

380

2.29

15.26

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

225

871

1.83

15.24

2.3

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

8.05

15.18

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

3127

19198

1.20

15.15

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

120

368

2.31

15.15

1.6

1.4

2096.17

3617.10

e6/l

0.38

252

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

4.66

15.07

1.2

1.4

316.73

345.41

pmol/l

0.10

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.21

14.76

1.1

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

7.33

14.76

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

4.29

14.76

1.9

—

(3006245) CD3-CD19+ cells/100 cells in Blood

122

3.35

14.64

2.0

1.7

10.77

13.59

0.82

116

(3020717) Zinc [Moles/volume] in Serum or Plasma

193

2.82

14.59

1.4

33.18

29.56

umol/l

0.34

188

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

124

3.30

14.29

2.0

1.6

29.40

26.71

0.68

119

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1267

7103

1.29

14.12

1.8

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

111

3.43

14.11

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

104

310

2.37

14.02

1.7

1.5

6.48

5.43

mmol/l

5.01

247

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.97

13.93

1.2

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

103

308

2.36

13.79

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

230

925

1.76

13.79

1.1

2.91

3.10

u/ml

0.11

115

563

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.82

13.69

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

332

2.30

13.61

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.74

13.54

1.0

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.07

13.53

1.1

96.49

93.41

0.24

(3034426) Prothrombin time (PT)

111

3.37

13.49

1.3

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

326

3514

0.64

13.49

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

325

3503

0.64

13.44

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.52

13.43

1.1

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.64

13.39

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.64

13.39

1.6

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

111

348

2.25

13.38

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

4.70

13.29

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

103

314

2.32

13.24

1.1

—

(4035726) Immunohistochemistry procedure

864

4643

1.33

13.10

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

338

3579

0.65

12.86

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

898

4868

1.32

12.81

3.2

4.9

9.22

39.36

ug/l

2.78

688

3810

(1761868) Lipid panel - Serum or Plasma

3734

23551

1.17

12.68

2.8

2.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

281

2.36

12.64

2.2

1.9

39.56

36.90

0.89

276

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2100

12598

1.21

12.63

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.80

12.42

1.6

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.65

12.33

1.9

1.6

222.14

783.00

e6/l

0.57

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.91

12.33

1.2

1.1

122.52

95.39

nmol/l

0.42

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

3.02

12.28

1.1

1.2

0.31

0.29

g/l

1.58

101

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

14.08

12.22

8.5

8.2

5.49

4.72

mmol/l

0.53

(3015183) Erythrocyte sedimentation rate

269

2.36

12.12

1.3

1.1

—

(3035880) pH of Pleural fluid

154

2.84

12.01

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

120

3.11

12.00

1.2

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

120

3.11

12.00

1.2

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.38

11.96

2.2

1.8

32.62

27.65

pmol/l

0.25

(3028433) Virus identified in Specimen by Culture

3.45

11.91

1.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

255

2.38

11.80

1.3

1.2

378.23

632.69

u/l

0.91

246

(3036782) Glucose [Moles/volume] in Pleural fluid

313

2.23

11.76

1.5

1.2

6.34

5.34

mmol/l

4.25

288

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.52

11.75

1.4

1.1

91.80

78.90

0.94

(3012441) Differential panel - Pleural fluid

100

319

2.21

11.63

1.6

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

15.64

11.59

2.0

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

101

3.28

11.56

2.8

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

11.91

11.45

1.2

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

155

2.77

11.37

1.3

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

155

2.77

11.37

1.3

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

2.75

11.37

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

3.48

11.30

1.8

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

144

2.84

11.27

1.2

105.58

109.63

0.27

131

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

420

4157

0.70

11.22

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

420

4154

0.70

11.18

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

130

2.93

11.08

1.1

1.2

113.71

108.97

0.56

119

(3045788) Cell count panel - Pleural fluid

303

2.21

11.08

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.67

11.00

1.9

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1988

12005

1.20

10.99

5.1

4.7

2.73

3.63

ug/l

1.40

1741

10970

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

264

2.30

10.96

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

2.87

10.92

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

419

4127

0.70

10.89

1.4

—

(40768806) Pleura Pathology biopsy report

102

338

2.13

10.85

1.7

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

3.06

10.81

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

4.95

10.79

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

422

4144

0.70

10.78

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.01

10.74

3.2

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.01

10.74

3.2

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

453

4386

0.71

10.64

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.94

10.52

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

101

338

2.11

10.49

1.6

1.4

26765.46

33557.06

e6/l

0.31

197

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

11.73

10.40

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

135

2.82

10.40

1.1

87.00

98.90

0.87

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

205

2.44

10.36

1.4

1.2

12.20

13.05

u/l

0.23

196

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

9.85

10.08

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.88

10.03

1.3

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1342

7865

1.23

10.03

1.5

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.24

9.71

2.0

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.24

9.71

1.3

1.1

82.63

68.19

0.78

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.17

9.65

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

137

2.73

9.64

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

174

2.51

9.62

1.1

1618.15

1324.11

miu/ml

1.06

174

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

947

8174

0.80

9.58

1.7

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

530

4925

0.74

9.55

1.5

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

142

2.68

9.52

1.1

85.58

96.35

1.07

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

11.51

9.35

1.1

—

(3022689) Creatine [Moles/volume] in Urine

4.40

9.14

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.70

9.14

1.9

1.4

9.77

9.59

ug/l

0.05

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.85

9.02

1.8

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

274

2.14

8.99

1.1

11.66

7.83

iu/ml

0.40

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

301

1443

1.48

8.96

1.3

1.4

104.80

125.29

pmol/l

0.38

293

1414

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

198

2.35

8.94

2.3

2.6

41.59

37.96

0.80

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

325

3230

0.70

8.93

1.7

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

143

2.61

8.92

1.6

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

171

1933

0.62

8.85

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.93

8.70

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.19

8.64

3.6

8.7

68.15

75.13

0.46

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

211

2.27

8.56

3.0

2.8

40782.59

42095.26

ug/l

0.22

211

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

372

3578

0.72

8.43

1.5

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

259

2.12

8.36

3.4

3.5

24.82

22.16

mu/l

0.29

243

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

13.19

8.31

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

214

970

1.56

8.30

4.2

2.3

22.36

27.54

mg/l

1.38

119

600

(3045683) HLA typing for celiac disease panel - Blood or Tissue

337

1.97

8.23

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

238

2.16

8.19

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

327

1.96

7.93

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

112

2.70

7.78

3.7

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2405

15127

1.15

7.71

1.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

15.24

7.65

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

15.24

7.65

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

122

2.60

7.56

1.4

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

275

2.03

7.54

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.07

7.38

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.61

7.35

5.7

5.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

271

2677

0.70

7.25

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

+∞

7.24

1.1

0.0

—

(3024471) HLA-A [Type]

2.80

7.17

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

3.24

7.13

2.3

20.71

80.78

u/l

0.88

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

122

2.54

7.10

1.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

122

2.54

7.10

1.4

1.9

—

(3024932) HLA-DR beta [Type]

2.82

7.04

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

276

1367

1.43

7.03

1.5

1.4

0.41

0.48

nmol/l

0.95

216

1109

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.45

7.02

1.1

1.0

0.50

0.64

umol/24h

1.05

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

184

2.22

7.01

1.1

90.60

90.01

0.06

135

(3003888) Timothy IgE Ab [Units/volume] in Serum

243

1180

1.46

6.88

1.0

1.1

3.83

5.71

u/ml

1.58

129

629

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

214

2.11

6.82

1.3

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.82

6.67

1.6

1.3

59.43

60.04

0.03

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

4.18

6.59

2.1

1.4

7.74

6.50

mmol/l

0.67

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.70

6.54

1.0

1.1

0.35

3.14

u/ml

0.53

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.29

6.47

1.0

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.97

6.47

1.4

1.9

118.03

113.80

au/ml

—

(3047189) Immunofixation for 24 hour Urine

2.75

6.41

1.9

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

111

457

1.71

6.39

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

264

1324

1.41

6.32

1.1

2.40

2.43

u/ml

0.01

128

672

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.38

6.31

1.1

1.63

2.11

mmol/l

0.68

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.12

6.28

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

461

2522

1.30

6.26

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

231

1134

1.44

6.22

1.0

1.1

0.60

1.13

u/ml

1.64

506

(44813793) Dust mix specific IgE antibody measurement

288

1.88

6.08

1.1

1.0

—

(21494434) Karyotype in Bone marrow

254

1.94

6.04

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

665

5670

0.81

5.98

1.5

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

8.31

5.95

3.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

357

1.78

5.92

1.2

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.92

5.89

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.38

5.86

1.2

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

9.38

5.86

1.6

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

400

1.73

5.85

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

6.21

5.73

1.2

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.63

5.69

1.3

1.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.20

5.68

1.5

1.7

0.46

0.79

mg/l

0.30

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.20

5.68

1.5

1.7

1.64

2.59

mg/l

0.32

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.20

5.68

1.5

1.7

1.14

5.08

mg/l

1.16

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.20

5.68

1.5

1.7

2.08

3.11

mg/l

0.24

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.20

5.68

1.5

1.7

0.81

4.16

mg/l

1.01

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.20

5.68

1.5

1.7

0.88

0.57

mg/l

0.18

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.82

5.54

3.2

3.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

116

2.37

5.52

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.36

5.50

1.3

2.3

—

(40768441) Liver Pathology biopsy report

324

1.78

5.49

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.07

5.49

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

439

2431

1.28

5.48

1.9

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1375

10927

0.87

5.42

1.6

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.78

5.41

1.1

1.0

78.71

85.44

ug/l

0.27

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.11

5.38

1.3

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.28

5.33

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.74

5.16

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.21

5.16

1.8

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

439

2451

1.27

5.15

1.4

1.3

232.06

232.98

miu/ml

0.02

220

1274

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.88

5.10

1.4

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.27

5.06

2.4

2.0

20.30

12.71

umol/l

1.49

(3006462) Nitrate [Presence] in Urine

206

1.95

5.04

2.8

2.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

440

1.63

5.03

1.3

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

193

1.97

4.93

1.1

1.0

4.49

7.48

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1570

9869

1.14

4.91

4.2

3.9

22.42

21.11

2.31

720

4941

(3043410) Blood group antigens tested for on Red Blood Cells

105

2.35

4.90

2.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

164

794

1.46

4.85

3.0

4.2

553.30

1357.40

u/ml

0.59

148

723

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.71

4.78

1.3

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

7.03

4.68

1.1

—

(3019174) dRVVT (LA screen)

4.59

4.61

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

189

950

1.40

4.59

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

301

1.73

4.57

1.8

1.3

75.69

79.99

umol/l

0.64

301

(3042517) Benzodiazepines panel - Urine

4.40

4.46

2.7

3.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.45

4.45

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.45

4.45

1.1

1.0

29.73

7.08

u/l

0.44

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

5.63

4.41

1.0

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.63

4.41

1.8

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.54

4.32

1.6

1.3

3.73

2.90

0.11

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.32

4.28

1.3

1.4

0.22

0.33

nmol/l

0.73

(3020874) Milk IgE Ab [Units/volume] in Serum

422

1.59

4.23

1.0

1.1

0.60

2.67

u/ml

1.24

115

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.51

4.21

1.3

1.2

22.22

358.35

ug/l

1.35

(3005011) Chlamydia sp Ab [Titer] in Serum

3.09

4.20

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

2.18

4.20

1.9

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2120

13683

1.11

4.19

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

224

1178

1.34

4.16

1.1

2.26

2.01

u/ml

0.14

108

597

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.15

4.09

1.6

1.3

11.64

18.96

0.35

(3036180) Methadone [Presence] in Urine

187

1.88

4.08

1.8

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

101

2.23

4.06

1.2

1.5

4.59

6.53

nmol/l

1.89

(40768800) Prostate Pathology biopsy report

106

1107

0.67

4.03

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.74

4.02

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.52

3.95

1.1

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.03

3.92

1.2

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.35

3.91

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

307

1703

1.27

3.89

2.8

4.1

281.93

1563.54

u/ml

2.10

262

1477

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

291

1.67

3.81

2.5

1.7

2.06

1.68

u/field

0.34

126

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

152

1.95

3.79

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

152

1.95

3.79

1.5

1.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.99

3.79

1.2

1.0

1.61

0.91

mmol/l

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.35

3.71

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

299

1.65

3.69

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

6.33

3.69

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

9.84

3.68

2.1

1.0

1.73

2.59

mu/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.79

3.68

1.7

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

257

1407

1.29

3.64

2.1

2.3

5.29

5.99

umol/l

0.50

180

1012

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

141

706

1.41

3.59

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

212

1134

1.32

3.57

2.0

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

106

506

1.48

3.48

1.5

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

162

1.87

3.48

1.0

1.1

3.13

7.05

u/ml

0.32

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

3.48

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.18

3.44

1.4

1.1

—

(40757373) Influenza virus identified in Isolate

2.56

3.42

1.9

1.3

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

4.30

3.35

1.0

0.17

0.16

u/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

216

1.73

3.35

2.5

1.5

1.05

2.59

u/field

2.24

150

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.84

3.27

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.93

3.26

2.8

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

136

1.91

3.24

2.1

2.9

161.50

162.36

au/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.03

3.15

1.3

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

7.03

3.15

1.9

1.3

555.81

286.34

nmol/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

189

1.75

3.13

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

208

1136

1.29

3.07

1.1

—

(3011288) Drugs identified in Urine by Screen method

307

1759

1.23

3.03

3.0

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.52

2.95

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

207

1137

1.28

2.94

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

148

776

1.34

2.93

2.5

2.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

116

1118

0.73

2.91

1.4

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.37

2.90

1.1

1.0

22.86

38.85

u/l

—

(3002619) Bacteria identified in Specimen by Culture

2.19

2.87

1.1

—

(4212803) Bone marrow aspirate examination

3.91

2.86

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

132

0.32

2.74

2.5

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

132

0.32

2.74

5.0

6.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.70

2.73

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.47

2.72

1.3

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

1.92

2.70

4.4

3.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1404

9077

1.10

2.68

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

466

2815

1.17

2.65

2.2

1.5

4.20

2.89

mg/l

2.22

377

1748

(3022475) Manganese [Moles/volume] in Blood

2.57

2.63

1.2

—

(3014891) Appearance of Pleural fluid

2.66

2.61

1.8

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.22

2.58

2.8

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.22

2.58

3.5

6.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.22

2.58

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.07

2.55

1.3

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.92

2.54

2.4

3.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1165

7485

1.10

2.53

3.0

2.9

0.73

0.86

ug/l

3.75

785

4752

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

490

2985

1.16

2.52

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

229

1304

1.24

2.46

1.6

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.45

2.42

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

162

1.69

2.40

1.3

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

429

1.41

2.37

1.0

1.1

6.89

3.50

u/ml

0.21

(3001729) Color of Synovial fluid

7.03

2.36

1.4

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.03

2.36

1.4

2.8

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

7.03

2.36

2.0

1.6

2.00

2.10

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

111

1.84

2.33

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

161

1.66

2.20

2.7

3.6

6.64

8.83

mg/l

1.54

134

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.51

2.17

2.9

1.6

51.50

44.13

umol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

3.51

2.17

6.3

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.85

2.15

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.86

2.14

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

5.86

2.14

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

912

1.26

2.10

1.2

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.79

2.09

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.98

2.02

5.3

7.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

204

1.55

2.02

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

103

946

0.76

1.98

1.4

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.70

1.98

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

347

2109

1.16

1.92

1.9

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.67

1.89

1.2

1.1

1.35

1.31

umol/24h

0.08

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

180

1.56

1.87

4.9

9.1

2638.00

11195.16

u/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.98

1.83

4.6

6.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

177

1018

1.23

1.83

1.1

3.10

3.43

u/ml

0.12

497

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

144

810

1.25

1.82

1.0

1.1

0.09

0.45

u/ml

1.24

189

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.39

1.79

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

4.39

1.79

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

195

1.52

1.74

1.1

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.74

1.69

1.1

1.2

—

1571.43

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.05

1.58

2.6

1.7

0.71

0.63

u/field

0.09

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.34

1.57

2.9

4.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.74

1.56

1.1

—

(3025130) Human papilloma virus identified in Specimen

222

1328

1.18

1.56

1.7

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.53

1.50

1.2

1.0

8.64

8.85

mmol/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.59

1.45

1.4

3.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

164

963

1.20

1.44

1.0

1.1

7.05

4.39

u/ml

0.28

413

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.27

1.42

1.5

1.2

462.80

324.16

umol/24h

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

223

1.42

1.40

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1551

10342

1.06

1.39

2.1

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.06

1.38

1.4

1.9

—

(40768793) Breast Pathology biopsy report

265

1628

1.15

1.36

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

184

1.45

1.34

1.1

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.78

1.34

1.5

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.64

1.32

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.85

1.32

2.0

1.6

—

(3048879) Bone marrow aspiration report

1.85

1.32

1.3

2.4

—

(3050794) Legionella sp Ab [Presence] in Serum

2.44

1.31

1.3

—

(40765096) Chromosome analysis panel by Banding

0.44

1.31

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.93

1.29

4.2

5.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

435

1.28

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.82

1.26

1.0

0.08

0.40

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

707

0.79

1.24

1.3

27.53

33.71

nmol/l

1.45

662

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.48

1.24

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.25

1.24

3.6

4.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.25

1.24

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.25

1.24

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.70

1.19

1.0

1.5

1.28

1.44

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.70

1.19

1.2

1.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.87

1.18

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.68

1.13

1.8

2.8

—

(40768795) Lymph node Pathology biopsy report

538

1.23

1.13

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

106

1.53

1.06

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.04

1.06

1.1

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

287

0.71

1.04

1.2

—

(3016879) Cocaine [Presence] in Urine

409

2628

1.10

1.04

1.8

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.95

1.03

1.0

3.91

7.38

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

969

6440

1.06

1.02

1.9

1.8

—

(3044007) Cell count panel - Peritoneal fluid

113

1.49

1.02

1.7

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.92

1.01

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.98

0.0

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

155

944

1.16

0.97

1.4

1.5

6.52

6.25

mmol/l

0.73

140

842

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.34

0.96

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.22

0.93

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.11

0.90

1.0

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

1.94

0.89

2.3

1.3

271.38

953.21

umol/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

319

1.26

0.88

1.3

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.60

0.86

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.60

0.86

1.8

1.3

19.52

21.70

0.10

(3020393) Adenovirus Ag [Presence] in Stool

1.81

0.85

1.0

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

127

0.61

0.85

2.5

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.92

0.82

3.3

2.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

124

1001

0.87

0.81

1.6

1.7

7.68

7.39

mmol/l

0.76

119

964

(3013862) HLA-DP [Type]

0.00

0.80

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.80

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.80

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.80

0.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.80

0.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

1.41

0.79

1.5

1.4

5035.23

5976.19

e6/l

0.13

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.79

0.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

408

1.21

0.78

1.0

0.21

1.36

u/ml

0.64

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

169

1.33

0.78

1.1

6.91

10.56

u/ml

0.55

106

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

338

1.23

0.77

1.7

2.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.60

0.77

3.7

3.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

121

1.39

0.77

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

121

1.39

0.77

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

121

1.39

0.77

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.49

0.76

1.1

1.0

0.01

0.03

u/ml

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

737

4915

1.06

0.75

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.48

0.69

1.3

1.1

15.49

12.84

g/l

0.57

(3023487) Leukocytes [#/volume] in Peritoneal fluid

136

1.34

0.69

1.6

1.5

655.41

1225.06

e6/l

0.90

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

224

1718

0.91

0.65

1.3

3.01

3.99

ug/l

0.73

199

1590

(3000764) Benzodiazepines [Presence] in Urine

442

2919

1.07

0.65

1.8

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.76

0.64

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.76

0.64

1.2

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.46

0.63

2.6

2.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

283

0.79

0.60

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.69

0.57

1.2

—

(3028300) Cannabinoids [Presence] in Urine

443

2946

1.06

0.55

1.8

1.5

—

(3027008) Opiates [Presence] in Urine

442

2944

1.06

0.53

1.8

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

348

1.17

0.53

1.3

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

1.49

0.51

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

370

1.16

0.49

1.1

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.60

0.46

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.41

0.45

1.1

—

(3027944) Amphetamines [Presence] in Urine

436

2921

1.05

0.45

1.8

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.46

0.44

1.4

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

406

0.86

0.43

1.4

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

129

1.25

0.42

1.7

2.2

1.17

4.05

ug/l

0.88

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

178

1172

1.07

0.36

3.2

3.4

26.21

36.74

u/ml

0.75

173

1131

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.36

0.34

1.2

1.3

—

(3033799) Differential panel - Peritoneal fluid

114

1.23

0.33

1.5

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

344

1.12

0.33

1.4

1.2

155.75

182.57

pmol/l

0.78

344

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

391

1.11

0.33

1.3

1.4

—

(4281824) Cell count and differential, peritoneal fluid

101

769

0.92

0.32

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

350

0.88

0.32

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.23

0.29

1.4

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

362

0.89

0.29

1.6

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.29

0.26

14.2

9.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

346

2513

0.97

0.24

2.2

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.21

0.22

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.22

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.1

—

35.43

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

208

1.12

0.20

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

572

0.95

0.16

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

104

1.15

0.16

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.17

0.15

6.4

6.9

—

(40758292) HTLV I+II Ab panel - Serum

0.87

0.11

1.1

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

374

1.05

0.11

2.6

3.3

—

(3020650) Glucose [Presence] in Urine

155

1.09

0.10

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

109

1.10

0.08

1.0

1.1

3.38

3.62

u/ml

0.02

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.02

0.07

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.02

0.07

7.1

4.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

681

1.02

0.05

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

148

1.04

0.03

3.0

2.6

68.05

103.83

ng/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.92

0.02

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

485

0.99

0.02

1.4

1.3

1.56

1.58

g/l

0.22

485

(3017509) Phencyclidine [Presence] in Urine

1.06

0.00

1.7

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.92

0.00

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.88

-0.00

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: THYROID_DISORDER_IBD – Disorders of thyroid, IBD co-morbidities

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Disorders of thyroid, IBD co-morbidities

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints